Akebia Therapeutics reported $39.42M in Stock for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Stock Change
Acadia Pharmaceuticals ACAD:US $ 7.01M 0.87M
Akebia Therapeutics AKBA:US $ 39.42M 1.23M
Alnylam Pharmaceuticals ALNY:US $ 78.52M 44.18M
Amgen AMGN:US $ 4411M 325M
Astellas Pharma 4503:JP Y 153072M 1496M
Bayer BAYN:GR € 10869M 445M
Biomarin Pharmaceutical BMRN:US $ 786.36M 9.69M
Exelixis EXEL:US $ 28.47M 0.97M
Fresenius Medical Care FME:GR € 2136.96M 98.95M
GlaxoSmithKline GSK:LN 6003M 220M
Johnson & Johnson JNJ:US $ 10990M 603M
Karyopharm Therapeutics KPTI:US $ 3.87M 232K
Moderna Inc MRNA:US 1.94B 501M
Nektar Therapeutics NKTR:US $ 15.38M 0.42M
Opko Health OPK:US 99.41M 12.9M
Ptc Therapeutics PTCT:US $ 15.28M 0.57M
Regeneron Pharmaceuticals REGN:US $ 1991.5M 488.7M
Sarepta Therapeutics SRPT:US $ 199M 12.78M
Seattle Genetics SGEN:US $ 275.75M 75.08M
Vanda Pharmaceuticals VNDA:US 1.29M 265K